CGC (Canopy Growth) Debt-to-Revenue : 1.34 (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Canopy Growth Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Canopy Growth's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $14.5 Mil. Canopy Growth's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $228.2 Mil. Canopy Growth's annualized Revenue for the quarter that ended in Mar. 2025 was $181.2 Mil. Canopy Growth's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 was 1.34.

Canopy Growth Debt-to-Revenue Historical Data

The historical data trend for Canopy Growth's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Debt-to-Revenue Chart

Canopy Growth Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Debt-to-Revenue

Get a 7-Day Free Trial

3.15

3.45

4.24

2.25

1.30

Canopy Growth Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Revenue	Get a 7-Day Free Trial															2.29	2.35	2.44	1.64	1.34

Competitive Comparison of Canopy Growth's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canopy Growth's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Canopy Growth's Debt-to-Revenue falls into.

Save Embed

;

Save Embed

;

Canopy Growth Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Canopy Growth's Debt-to-Revenue for the fiscal year that ended in Mar. 2025 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(14.489	+	228.195)	/	187.375
	=	1.30

Canopy Growth's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(14.489	+	228.195)	/	181.196
	=	1.34

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2025) Revenue data.

Canopy Growth Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (NAS:CGC) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

11L:Germany WEED:Canada

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Executives

Theresa Yanofsky	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
David Angelo Lazzarato	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Christelle Gedeon	officer: See Remarks	3 HOLLYHOCK COURT, TORONTO Z4 M3B 0B4
Hong Judy Eun Joo	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS Z4 K7A 0A8
David Eric Klein	director, officer: Chief Executive Officer	207 HIGH POINT DRIVE, VICTOR NY 14564
Judy Schmeling	director	C/O HSN, INC., 1 HSN DRIVE, ST.PETERSBURG FL 33729
Thomas Carlton Stewart	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Garth Hankinson	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Greenstar Ii Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Ii Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Rade Nikola Kovacevic	officer: President	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Phillip Stephen Shaer	officer: Chief Legal Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Grant Julious C. Jr	officer: Chief Commercial Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Sabia James A. Jr.	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Tomas Iv Shipley	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8